UNITAID working with travel web sites to raise donations for HIV/AIDS, tuberculosis and malaria

NewsGuard 100/100 Score

Philippe Douste-Blazy, former French foreign minister and head of UNITAID, announced recently that he is in talks with online travel industry CEOs to allow air travelers booking online to make a $2 per-flight donation to HIV/AIDS, tuberculosis and malaria efforts worldwide, the Financial Times reports.

The global financial crisis has placed some governments' foreign aid budgets "under pressure," and the United Nations is "turning to private industry and individuals to finance the battle against" the three diseases, according to the Times.

According to Douste-Blazy, he has contacted CEOs from top online travel companies and received a positive response. According to the Times, the companies Travelport and Amadeus confirmed that they are in talks with UNITAID, and a United Kingdom spokesperson for Travelport said that the company had its most recent talks with the agency last week. The spokesperson added that the company is working on prototypes for online donations. Amadeus said that it is working with UNITAID and others to develop systems for micro-contributions that could be adopted by other industries.

According to the Times, UNITAID aims to raise more than $1 billion annually for HIV/AIDS, TB and malaria efforts. It has raised $600 million during the past two years through a tax on airline tickets implemented by one dozen participating countries. One flight with 300 passengers could raise enough funds to provide 60 HIV-positive children with treatment for one year, the Times reports (Morris, Financial Times, 3/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows